于波中國(guó)醫(yī)大一院-免費(fèi)閱讀
【正文】 P=) ?副作用相似 ?結(jié)論：秋水仙堿安全有效地減少 POAF，減少住院日 Spyridon Deftereos , J Am Coll Cardiol. 2022, 60(18): 1790–1796 3個(gè)月后秋水仙堿組早期房顫復(fù)發(fā)率明顯低于安慰劑組 他汀類藥物與房顫復(fù)發(fā) ? Suleiman，前瞻性，隨機(jī)，安慰劑對(duì)照研究，分析有癥狀房顫患者經(jīng) PVI后 AF復(fù)發(fā)而沒有使用至少一種 AAD患者應(yīng)用他汀類藥物效果 ? 結(jié)論：消融前阿托伐他汀 80mg/天并不降低前 3個(gè)月房顫復(fù)發(fā)風(fēng)險(xiǎn)，不應(yīng)常規(guī)給予預(yù)防圍手術(shù)期心律失常 雷諾嗪與房顫復(fù)發(fā) Heart Rhythm, Vol 9, No 4, April 2022 2022 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Remendations for Patient Selection, Procedural Techniques, Patient Management and Followup, Definitions, Endpoints, and Research Trial Design The European AF Ablation Pilot registry Study: The EURObservational Research Programme (EORP) ? a prospective registry to describe the clinical epidemiology of AF ablation, and the diagnostic/therapeutic processes applied in Europe ? Arrhythmia documentation was done by an ECG in 76%, Holter in 52%, transtelephonic monitoring in 8%, and/or implanted systems in % Eur Heart J June 21, 2022 35 (24) First published online: January 31, 2022 72 centres in 10 countries to enrol 20pts doing a 1st PVI Oct, 2022 May, 2022 1391 pts PVI(%),1300 pts (%) pleted followup 367 177。 procedures， 142 pts on RASI ?Median followup ( ) yrs Takigawa M et al. Journal of ReninAngiotensinAldosterone System 2022。4(1):114 ?PVI后短期（最初 6周）減少房性心律失常早期復(fù)發(fā) ?6個(gè)月時(shí)，有癥狀性或無癥狀房性心律失常發(fā)生率 2組無差異 The only predictor of freedom from AF at 6M was lack of early AF occurrence during the 6week blanking period LeongSit P et al Circ Arrhythm Electrophysiol. 2022 Feb。 65 Prior AADs 177。upstream therapy‘ ? from 1 Jan, 2022 to 1 Feb, 2022 ?w/t language limitation Expert Rev CardiovascTher. 2022。 days after PVI ERAF similar in paroxysmal and persistent AF (33% and 47%, p = ) KaplanMeier analysis of longterm freedom from recurrent AF in pts with and without an ERAF Oral H , Knight BP, J Am Coll Cardiol. 2022 Jul 3。40(1):1004. ?ERAF are associated with a lower longterm success rate ?temporary AAD may be more appropriate than early repeat ablation in pts with ERAF At 208 177。11(7):837842 ?消融后早期使用 AAD為了減少房性心律失?；蜃蠓看笳鄯敌苑克僭缙趶?fù)發(fā) ?早期
語文相關(guān)推薦
鄂ICP備17016276號(hào)-1